Exelixis, Inc.

    EXEL ·NASDAQ ·Biological Products, (No Diagnostic Substances) ·Inc. in DE
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-05-12 10-Q expected by 2026-05-20 (in 11 days)
    • ~2026-07-27 10-Q expected by 2026-08-04 (in 87 days)
    • ~2026-11-03 10-Q expected by 2026-11-11 (in 186 days)
    • ~2027-02-09 10-K expected by 2027-03-02 (in 284 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-15 DEF 14A Proxy Statement
    • 2026-02-10 10-K Annual Report
    • 2026-02-10 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-01-12 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-11-07 8-K Officer/Director Change; Other Events
    • 2025-11-04 10-Q Quarterly Report
    • 2025-11-04 8-K Earnings Release; Other Events; Financial Statements and Exhibits
    • 2025-08-29 8-K Officer/Director Change
    • 2025-07-28 10-Q Quarterly Report
    • 2025-07-28 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-05-13 10-Q Quarterly Report
    • 2025-05-13 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-03-31 8-K Officer/Director Change
    • 2025-02-21 8-K Other Events; Financial Statements and Exhibits
    • 2025-02-11 10-K Annual Report